Retargeting Clostridium difficile toxin B to neuronal cells as a potential vehicle for cytosolic delivery of therapeutic biomolecules to treat botulism

Journal of Toxicology

Volumn 2012, Issue , 2012, Pages

  Krautz Peterson, Greice ^a   Zhang, Yongrong ^a   Chen, Kevin ^a   Oyler, George A ^b   Feng, Hanping ^a   Shoemaker, Charles B ^a  

^a TUFTS UNIVERSITY   (United States)

^b SYNAPTIC RESEARCH LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLTRANSFERASE; BOTULINUM TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; GLUCOSYLTRANSFERASE; STREPTAVIDIN; TRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BOTULISM; CHIMERA; CYTOSOL; ENZYME ACTIVITY; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION;

CLOSTRIDIUM DIFFICILE;

EID: 81555221763     PISSN: 16878191     EISSN: 16878205     Source Type: Journal    
DOI: 10.1155/2012/760142     Document Type: Article

References (30)

1. Jank T., Aktories K., Structure and mode of action of clostridial glucosylating toxins: the ABCD model Trends in Microbiology 2008 16 5 222 229
2. Egerer M., Giesemann T., Jank T., Fullner Satchell K. J., Aktories K., Auto-catalytic cleavage of Clostridium difficile toxins A and B depends on cysteine protease activity Journal of Biological Chemistry 2007 282 35 25314 25321 (Pubitemid 47372781)
3. Giesemann T., Egerer M., Jank T., Aktories K., Processing of Clostridium difficile toxins Journal of Medical Microbiology 2008 57 6 690 696 (Pubitemid 351842059)
4. Egerer M., Giesemann T., Herrmann C., Aktorles K., Autocatalytic processing of Clostridium difficile toxin B: binding of inositol hexakisphosphate Journal of Biological Chemistry 2009 284 6 3389 3395
5. Voth D. E., Ballard J. D., Clostridium difficile toxins: mechanism of action and role in disease Clinical Microbiology Reviews 2005 18 2 247 263 (Pubitemid 40548293)
6. He X., Sun X., Wang J., Wang X., Zhang Q., Tzipori S., Feng H., Antibody-enhanced, Fc receptor-mediated endocytosis of Clostridium difficile toxin A Infection and Immunity 2009 77 6 2294 2303
7. Steele J., Feng H., Parry N., Tzipori S., Piglet models of acute or chronic Clostridium difficile illness Journal of Infectious Diseases 2010 201 3 428 434
8. Yang G., Zhou B., Wang J., He X., Sun X., Nie W., Tzipori S., Feng H., Expression of recombinant Clostridium difficile toxin A and B in Bacillus megaterium BMC Microbiology 2008 8, article 192
9. Simpson L. L., Identification of the major steps in botulinum toxin action Annual Review of Pharmacology and Toxicology 2004 44 167 193 (Pubitemid 38263838)
10. Davletov B., Bajohrs M., Binz T., Beyond BOTOX: advantages and limitations of individual botulinum neurotoxins Trends in Neurosciences 2005 28 8 446 452 (Pubitemid 40982558)
11. Verderio C., Rossetto O., Grumelli C., Frassoni C., Montecucco C., Matteoli M., Entering neurons: botulinum toxins and synaptic vesicle recycling EMBO Reports 2006 7 10 995 999 (Pubitemid 44480513)
12. Schmidt J. J., Stafford R. G., Bostian K. A., Type A botulinum neurotoxin proteolytic activity: development of competitive inhibitors and implications for substrate specificity at the S1' binding subsite FEBS Letters 1998 435 1 61 64 (Pubitemid 28432015)
13. Tremblay J. M., Kuo C. L., Abeijon C., Sepulveda J., Oyler G., Hu X., Jin M. M., Shoemaker C. B., Camelid single domain antibodies (VHHs) as neuronal cell intrabody binding agents and inhibitors of Clostridium botulinum neurotoxin (BoNT) proteases Toxicon 2010 56 6 990 998
14. Dong J., Thompson A. A., Fan Y., Lou J., Conrad F., Ho M., Pires-Alves M., Wilson B. A., Stevens R. C., Marks J. D., A single-domain llama antibody potently inhibits the enzymatic activity of botulinum neurotoxin by binding to the non-catalytic -exosite binding region Journal of Molecular Biology 2010 397 4 1106 1118
15. Tsai Y. C., Maditz R., Kuo C. L., Fishman P. S., Shoemaker C. B., Oyler G. A., Weissman A. M., Targeting botulinum neurotoxin persistence by the ubiquitin-proteasome system Proceedings of the National Academy of Sciences of the United States of America 2010 107 38 16554 16559
16. Kuo C. L., Oyler G. A., Shoemaker C. B., Accelerated neuronal cell recovery from botulinum neurotoxin intoxication by targeted ubiquitination PLoS ONE 2011 6 5
17. Keppler A., Gendreizig S., Gronemeyer T., Pick H., Vogel H., Johnsson K., A general method for the covalent labeling of fusion proteins with small molecules in vivo Nature Biotechnology 2003 21 1 86 89 (Pubitemid 36055833)
18. LaPenotiere H. F., Clayton M. A., Middlebrook J. L., Expression of a large, nontoxic fragment of botulinum neurotoxin serotype A and its use as an immunogen Toxicon 1995 33 10 1383 1386
19. Shoshan M. C., Bergman T., Thelestam M., Florin I., Dithiothreitol generates an activated 250,000 mol. wt form of Clostridium difficile toxin B Toxicon 1993 31 7 845 852
20. Lalli G., Herreros J., Osborne S. L., Montecucco C., Rossetto O., Schiavo G., Functional characterisation of tetanus and botulinum neurotoxins binding domains Journal of Cell Science 1999 112 16 2715 2724 (Pubitemid 29429794)
21. Park J. B., Simpson L. L., Inhalational poisoning by botulinum toxin and inhalation vaccination with its heavy-chain component Infection and Immunity 2003 71 3 1147 1154 (Pubitemid 36254295)
22. Pfeifer G., Schirmer J., Leemhuis J., Busch C., Meyer D. K., Aktories K., Barth H., Cellular uptake of Clostridium difficile toxin B. Translocation of the N-terminal catalytic domain into the cytosol of eukaryotic cells Journal of Biological Chemistry 2003 278 45 44535 44541 (Pubitemid 37377206)
23. Genisyuerek S., Papatheodorou P., Guttenberg G., Schubert R., Benz R., Aktories K., Structural determinants for membrane insertion, pore formation and translocation of Clostridium difficile toxin B Molecular Microbiology 2011 79 6 1643 1654
24. Sundriyal A., Roberts A. K., Ling R., McGlashan J., Shone C. C., Acharya K. R., Expression, purification and cell cytotoxicity of actin-modifying binary toxin from Clostridium difficile Protein Expression and Purification 2010 74 1 42 48
25. Dingle T., Wee S., Mulvey G. L., Greco A., Kitova E. N., Sun J., Lin S., Klassen J. S., Palcic M. M., Ng K. K. S., Armstrong G. D., Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile Glycobiology 2008 18 9 698 706
26. Barroso L. A., Moncrief J. S., Lyerly D. M., Wilkins T. D., Mutagenesis of the Clostridium difficile toxin B gene and effect on cytotoxic activity Microbial Pathogenesis 1994 16 4 297 303 (Pubitemid 24253074)
27. Kern S. M., Feig A. L., Adaptation of Clostridium difficile toxin A for use as a protein translocation system Biochemical and Biophysical Research Communications 2011 405 4 570 574
28. Zhang P., Ray R., Singh B. R., Li D., Adler M., Ray P., An efficient drug delivery vehicle for botulism countermeasure BMC Pharmacology 2009 9, article 12
29. Ho M., Chang L.-H., Pires-Alves M., Thyagarajan B., Bloom J. E., Gu Z., Aberle K. K., Teymorian S. A., Bannai Y., Johnson S. C., McArdle J. J., Wilson B. A., Recombinant botulinum neurotoxin A heavy chain-based delivery vehicles for neuronal cell targeting Protein Engineering, Design and Selection 2011 24 3 247 253
30. A. B.Maksymowych and L. L. Simpson, "Structural features of the botulinum neurotoxin molecule that govern binding and transcytosis across polarized human intestinal epithelial cells," Journal of Pharmacology and Experimental Therapeutics, vol. 310, no. 2, pp. 633-641, 2004. (Pubitemid 38988908)